Evidence map›Paper›PMID 29081002›Full record

ArticleNeurochemical research2018

Minocycline Directly Enhances the Self-Renewal of Adult Neural Precursor Cells.

Anri Kuroda, Takahiro Fuchigami, Satoshi Fuke, Natsu Koyama, Kazuhiro Ikenaka, Seiji Hitoshi

Abstract read
PubMed Publisher
In one paragraph

Article in Neurochemical research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Anri KurodaDepartment of Integrative Physiology, Shiga University of Medical Science, Otsu, 520-2192, Japan.
Takahiro FuchigamiDepartment of Integrative Physiology, Shiga University of Medical Science, Otsu, 520-2192, Japan.
Satoshi FukeDepartment of Integrative Physiology, Shiga University of Medical Science, Otsu, 520-2192, Japan.
Natsu KoyamaDepartment of Integrative Physiology, Shiga University of Medical Science, Otsu, 520-2192, Japan.
Kazuhiro IkenakaDivision of Neurobiology and Bioinformatics, National Institute for Physiological Sciences, Okazaki, 444-8787, Japan.
Seiji HitoshiDepartment of Integrative Physiology, Shiga University of Medical Science, Otsu, 520-2192, Japan. shitoshi-tky@umin.ac.jp.ORCID http://orcid.org/0000-0002-6339-6802
Shiga University of Medical Science · JPThe Graduate University for Advanced Studies, SOKENDAI · JP

Funding

The Ministry of Education, Culture, Sports, Science and Technology of Japan 16H04671, 16K14578
6 · The paper itself

Abstract

Minocycline not only has antibacterial action but also produces a variety of pharmacological effects. It has drawn considerable attention as a therapeutic agent for symptoms caused by inflammation in many neurological disorders, leading to several clinical trials. Although some of these effects are mediated through its function of suppressing microglial activation, it is not clear whether minocycline acts on other cell types in the adult brain. In this study, we utilized a colony-forming neurosphere assay, in which neural stem cells (NSCs) clonally proliferate to form floating colonies, called neurospheres. We found that minocycline (at therapeutically relevant concentrations in cerebrospinal fluid) enhances the self-renewal capability of NSCs derived from the subependymal zone of adult mouse brain and facilitates their differentiation into oligodendrocytes. Importantly, these effects were independent of a suppression of microglial activation and were specifically observed with minocycline (among tetracycline derivatives). In addition, the size of the NSC population in the adult brain was increased when minocycline was infused into the lateral ventricle by an osmotic minipump in vivo. While precise molecular mechanisms of how minocycline alters the behavior of adult NSCs remain unknown, our data provide a basis for the clinical use of minocycline to treat neurodegenerative and demyelinating diseases.

Indexed as

AnimalsBrainCell DifferentiationCells, CulturedCell SurvivalMaleMiceMinocyclineNeural Stem CellsOligodendrogliaMinocyclineMicrogliaNeural stem cellOligodendrocyteSelf-renewal

Identifiers

PMID29081002
OpenAlexW2765741297

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.